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Electrospun fibroin/polyurethane meshes: manufacturing, characterization and 
potentialities as substrates for haemodialysis arteriovenous grafts 
 
Abstract: Several attempts made so far to combine silk fibroin and polyurethane, in order 
to prepare scaffolds encompassing the bioactivity of the former with the elasticity of the 
latter, suffer from critical drawbacks concerning industrial and clinical applicability (e.g., 
separation of phases upon processing, use of solvents unaddressed by the European 
Pharmacopoeia, use of degradable polyurethanes). Overcoming these limitations, in this 
study we report the successful blending of regenerated silk fibroin with a medical-grade, non-
degradable polyurethane using formic acid and dichloromethane, and the manufacturing of 
hybrid, semi-degradable electrospun tubular meshes with different ratios of the two materials. 
Physicochemical analyses demonstrated the maintenance of the characteristic features of 
fibroin and polyurethane upon solubilisation, blending, electrospinning and post-processing 
with ethanol or methanol. Envisioning their possible application as semi-degradable 
substrates for haemodialysis arteriovenous grafts, tubular meshes were further characterized, 
showing sub-micrometric fibrous morphologies, tuneable mechanical properties, permeability 
before and after puncture in the same order of magnitude as commercial grafts currently used 
in the clinics. Results demonstrate the potential of this material for the development of 
hybrid, new-generation vascular grafts with disruptive potential in the field of in situ tissue 
engineering. 
 
Keywords: hybrid, semi-degradable material, polyurethane fibroin blend, electrospun 
vascular graft, haemodialysis; 
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In situ tissue engineering strategies, which rely on the patient’s body as a bioreactor in 
alternative to in vitro culture before implantation, have been showing disruptive potential for 
clinical cardiovascular applications
(1)–(5)
. This approach, lately also called “endogenous tissue 
regeneration”, proposes ready-to-use biodegradable scaffolds, with low manufacturing cost 
and lead time, designed to improve local tissue functionality while triggering regeneration. In 
this scenario, arteriovenous vascular grafts for haemodialysis represent a particularly 
interesting application of in situ tissue engineering, since these scaffolds could be used as 
“off-the-shelf” prostheses, offering the ultimate valuable and durable vascular access 
alternative for patients in the need for long-term haemodialysis, currently facing the choice 
between suboptimal alternatives, i.e. native fistulae or fully synthetic grafts
(6)
. In fact, if 
properly designed, biodegradable arteriovenous vascular grafts would allow for immediate 
puncturing after implantation (early cannulation), thus enabling urgent haemodialysis, and 
would progressively evolve into a healthy native vascular tissue, granting superior patency on 
the long term. However, considering the acellular character of this approach, the successful 
outcome relies exclusively on the scaffold’s material. This requires extra material engineering 
focus on the development of scaffolds that possess the desired predictable dynamic response 
at short-, medium- and long-term after implantation. 
In this direction, one promising strategy consists in combining a natural degradable 
material with a synthetic inert polymer, providing a “hybrid” alternative to the puristic in situ 
tissue engineering approach, which encompasses fully degradable scaffolds. Indeed, the 
implantation of a semi-degradable vascular graft would safeguard the mechanical 
functionality in the long-run, since the non-degradable material would remain inert in situ, 
while the natural material would be progressively replaced by newly developed tissue. 
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Silk fibroin and polyurethane are two possible candidates to pursue the “hybrid” goal. Silk 
fibroin has been approved by the US Food and Drug Administration (FDA) to be used 
in the form of surgical suture
(7)
, it has demonstrated to induce a negligible 
inflammatory response
(8),(9)
, to possess good biocompatibility properties in vitro and in 
vivo (rats)
(10)
, and suitable hemocompatibility in a canine model
(11)
. Additionally, Zhang 
et al. demonstrated how ePTFE grafts (under commercialization for vascular access 
application), when coated internally with a layer of silk fibroin, increased their 
hemocompatibility in rabbits as a result of a natural development of a layer of 
endothelial cells, resembling the morphology of the intima layer in native blood 
vessels
(12)
. As regards polyurethanes, their overall biocompatibility properties are 
generally deemed to be good; however, as addressed in the following, the wide range of 
possible formulations might significantly influence their degree of biocompatibility
(13)
. 
The combination of polyurethane and silk fibroin has already been proposed in different 
formulations, morphologies, and ratios
(14)–(34)
 with the aim to prepare scaffolds encompassing 
the bioactive compatibility and degradability of fibroin together with the elasticity and long-
term biostability of polyurethanes. Studies that report the coupling of these two materials, 
however, have one or more critical drawbacks concerning industrial and clinical applicability. 
The majority of these works use solvents unaddressed or belonging to Class 1 (Solvents to 
be avoided) in the European Pharmacopoeia
(14)–(20),(35)
 (e.g. hexa-fluoro-isopropanol, also 
characterized by exorbitant costs, extreme volatility and difficult manageability), or 
polyurethanes that are degradable and/or not suitable for long-term medical application
(18)–
(28)(36)
, which would unlikely pass the exam of regulatory approval necessary for product 
certification and commercialization. Other works report the development of composite 
scaffolds
(14),(15),(22),(29)–(32),(37)
, where fibroin and polyurethane are present in different, non-
coalescent phases, and are therefore highly susceptible to separation and delamination
(30)
, 
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especially upon post-processing treatments (such as crystallization and sterilization, known to 
induce different volumetric changes in the natural and in the synthetic phases) or during in 
vivo remodelling. Both Bai et al.
(27)
 and Liu et al.
(26)
 report effective electrospinning of a 
polyurethane solution containing dispersed fibroin particles. This strategy potentially 
succeeds in gathering the elastic properties of polyurethane with the biocompatibility of silk 
fibroin; however, upon electrospinning, the non-dissolved fibroin particles are trapped inside 
polyurethane fibres, possibly hindering the fibres’ mechanical resistance and reducing surface 
exposure suitable for cell attachment, therefore hampering the bioactive potential of fibroin. 
Iizuka et al.
(34)
 developed an interesting method to blend fibroin and polyurethane using an 
organic solvent addressed by the European Pharmacopoeia. However, this strategy results in 
a blend with unknown concentrations of fibroin, possibly failing to achieve consistent results 
from different batches.  
Herein, the development of a hybrid semi-degradable material made of fibroin and 
polyurethane is reported with the potential for in situ vascular tissue engineering applications, 
such as innovative arteriovenous vascular grafts for haemodialysis. Overcoming the 
limitations of the above cited studies, we processed a blend of regenerated silk fibroin with a 
medical-grade
(38)
, non-degradable polyurethane to prepare electrospun semi-degradable 
hybrid tubular scaffolds with an extracellular matrix-like morphology. The proposed method 
makes use of a novel sustainable solvent system complying with the directions of the 
European Pharmacopoeia for the development of medical implants
(35)
. The effects produced 
on the raw materials by the solvent mixture, blending, electrospinning, and post-processing 
treatments were investigated in order to successfully maintain the intrinsic properties 
associated to fibroin and polyurethane. Moreover, the versatility of the proposed process was 
demonstrated, allowing for the manufacturing of meshes with tuneable concentrations of raw 
materials, which were characterized in terms of mechanical properties, morphology and 
Page 5 of 37
John Wiley & Sons, Inc.
































































permeability. Finally, in anticipation of their possible application as substrates for 
arteriovenous vascular grafts, the permeability of the meshes after puncture was assessed. 
2. Materials and Methods 
2.1 Materials 
Bombyx mori cocoons were provided by the Council of Research and Experiments in 
Agriculture, Apiculture and Sericulture Unit (CREA-API; Padua, Italy). Poly-carbonate-
urethane (Carbothane
®
 Aromatic, AC–4075A) pellets (PP, polyurethane pellets) were kindly 
supplied by Lubrizol (Wickliffe, OH, United States). All other chemical reagents were 
obtained from Carlo Erba (Cornaredo, Italy) unless otherwise mentioned. 
2.2 Preparation of regenerated Bombyx mori silk fibroin 
Bombyx mori cocoons were degummed at 120°C for 15 min and washed to extract the 
sericin. Extracted fibroin fibres were solubilized in a 9.3 M lithium bromide solution (T = 60 
± 2°C, t = 3h under shaking) to obtain a final concentration of 10% w/v fibroin. The solution 
was then diluted with warm deionized water to obtain a 2% w/v fibroin concentration, filtered 
and dialyzed for three days using cellulose membrane tubing (Mw cut-off = 14,000 Da) to 
eliminate lithium bromide salts. Finally, fibroin films (FF) were prepared by solvent casting. 
Please, refer to Table 1 for the complete list of the samples and acronyms used in this study. 
2.3 Blending silk fibroin and polyurethane 
The fibroin/polyurethane blend solution was prepared by first dissolving each raw material 
separately and later joining them into one solution. Briefly, fibroin films were cut into small 
pieces and dissolved (T = room temperature (RT), t = 1h, 150 rpm) in formic acid (FA). In 
parallel, polyurethane was dissolved (T = RT, t = 1h, 250 rpm) in a 1:2 ratio of FA and 
dichloromethane (DCM), respectively. The polyurethane solution was then progressively 
transferred into the fibroin solution and further stirred (T = RT, t = 15 min, 150 rpm) to 
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achieve a blend solution with a final concentration of 2% w/v of each material within a 3:2 
ratio of FA and DCM, respectively. 
The blend solution was either used to produce blend films by solvent casting (BFS), to 
evaluate the blending effect on the raw materials, or to prepare blend electrospun samples 
(ENC, electrospun non-crystallized), using the parameters described in Table 1, to assess 
potential damages induced by electrospinning. Moreover, in order to evaluate the effect of 
solvents on the single raw materials, control films of pure fibroin (FFS) and pure 
polyurethane (PFS) were prepared by casting solutions prepared as described above for the 
blend, but skipping the addition of polyurethane and fibroin, respectively. 
Finally, with the aim of developing a more industrially-sustainable crystallization 
treatment for silk fibroin, as an alternative to the common practice with methanol, an ethanol-
based process was tested. Ethanol-crystallized electrospun blend samples (EtOH) were 
prepared by post-treating ENC samples in a descending series of ethanol/demineralized water 
solutions, upon stirring at 150 rpm: 50% v/v (1h), 50% v/v (15h), 25% v/v (1h), 25% v/v 
(1h), 100% H2O (1h). EtOH samples were used to evaluate the post-treatment effect on the 
raw materials, the development of β-sheet conformations and the removal efficiency of 
solvents. As a control, methanol-crystallized electrospun blend samples (MeOH) were 
prepared by dipping ENC samples in a solution of 80% v/v methanol/demineralized water for 
10 minutes. 
2.4 Electrospinning of hybrid tubular meshes 
The feasibility of manufacturing hybrid electrospun tubular meshes with tuneable 
fibroin/polyurethane ratios was evaluated by processing the following different blend 
solutions: 1% w/v fibroin and 3% w/v polyurethane (SF25PU75), 2% w/v fibroin and 2% w/v 
polyurethane (SF50PU50), and 3% w/v fibroin and 1% w/v polyurethane (SF75PU25). The 
samples were electrospun using the same electrospinning parameters employed on the 
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preparation of samples ENC, EtOH and MeOH (Table 1). Briefly, the blend solution was 
loaded into a solvent resistant syringe controlled by a pump delivering a constant flow rate 
(2.5 mL/h) to a spinneret (+17 kV), which was moving (velocity = 5 mm/s; path length = 20 
cm) in parallel to a rotating (1000 rpm) metal rod collector (diameter = 8 mm; L = 32 cm), 
covered with aluminium foil, over a total period of 8 hours for each formulation. Electrospun 
hybrid tubular meshes were post-treated using the same crystallization protocol described 
above to prepare EtOH samples.  
2.5 Characterization 
2.5.1 Physicochemical properties 
Physicochemical analyses were made on samples PP, PFS, FF, FFS, BFS, ENC, EtOH and 
MeOH, by Fourier transform infrared (FTIR) spectroscopy (N=3) and differential scanning 
calorimetry (DSC), to evaluate the effects of solvent mixture, blending, electrospinning, and 
post-treatment on the raw materials. FTIR was performed using an attenuated total 





, with a resolution of 1.42 cm
-1
. The absorption peak of amide I (1703-1605 cm
-1
) 
was deconvoluted using OriginPro (version 9.1; OriginLab Corporation, United States) by 
adapting a protocol previously reported
(39)
. For the quantification of the samples’ crystallinity 
index (Ci), the different contributions were fit using Gaussian peaks. In the samples with 
polyurethane and silk blends (BFS, ENC, EtOH and MeOH), the polyurethane contribution 
was fit together with the silk, with a methodology described in detail in the Supplementary 
Information. 
DSC measurements were acquired with a DSC Q200 (TA Instruments; United States) 
during three heating cycles alternated with periods of cooling and temperature maintenance 
(see Supplementary Information). The second derivative of heat flow during the heating ramp 
was used to find the glass (Tg), crystallization (Tc) and degradation (Td) temperatures. 
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2.5.2 Structure and morphology 
The fibrous morphology of samples SF25PU75, SF50PU50, and SF75PU25 was analysed 
by scanning electron microscopy (SEM). Briefly, each sample was coated with a layer of 
gold and further observed under a SEM equipment (MIRA3; Tescan, Czech Republic) 
operating at 10 kV. The diameter of fibres at 5000x magnification was measured using 
ImageJ software (ImageJ 1.50i; National Institutes of Health, United States) for  at least 249 
fibres. 
2.5.3 Mechanical properties 
Uniaxial tensile tests were performed on samples SF25PU75, SF50PU50, and SF75PU25, 
after cutting dog-bone shaped specimens in the longitudinal direction from opened and 
flattened electrospun tubular matrices. Tensile properties were measured at RT, after 
hydrating the samples in distilled water for 10 minutes, using a tensile testing system (LF 
Plus; Lloyd Instruments, United Kingdom), with a load cell of 100 N, at 100 mm.min
-1
 until 
break. Strain was calculated in relation to the 24 mm gauge length and stress was calculated 
in relation to a cross-sectional area with 5 mm width and the average thickness measured 
using a micrometre before starting the test (293-805; Mitutoyo, Japan). Young’s modulus was 
retrieved by doing a linear regression of the elastic domain in each sample. Maximum 
elongation at break, stress at break and Young’s modulus were averaged from 3 replicates 
and corresponding standard deviations were calculated for each condition. Dog-bone 
specimens derived from a commercial ePTFE (expanded polytetrafluoroethylene) graft 
were similarly tested as a term of comparison (n=2). 
2.5.4 Permeability before and after puncture 
Water permeability was measured on samples SF25PU75, SF50PU50, SF75PU25 and on 
commercial arteriovenous vascular grafts: a polyurethane electrospun graft (ES PU), an 
ePTFE prosthesis graft, and a three-layered arteriovenous vascular graft containing ePTFE 
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(3-layer ePTFE). Briefly, a 14 mm diameter circular punch was used to cut samples with 
consistent size, after longitudinally opening and flattening the electrospun tubular matrices 
(N≥3 for SF25PU75, SF50PU50, SF75PU25, N=1 for commercial grafts). Each sample was 
hydrated (demineralised water; t > 10 min) and assembled in a cylindrical chamber held 
between two silicon O-rings that allowed a circular perfused area with a diameter of 11 mm. 
Each test was conducted at a constant pressure of 120 mmHg for 6 hours. The volume of 
diffused demineralised water was measured at each hour. The flow rate was further used to 
calculate the permeability k using Darcy equation (Eq. 1): 
 =
 ∙  ∙ ∆
 ∙ 	
																																														(Equation	1)		 
In Eq. 1, Q is the flow rate, A is the cross-sectional perfused area, ΔP is the relative 
pressure of the medium at the sample location, µ is the viscosity of the medium used, and L is 
the thickness of the sample. 
Following these tests, samples were punctured under 120 mmHg with a 15G 
haemodialysis needle. The volume of water permeated through the sample was collected for 1 
minute, after retrieval of the needle. The measured flow rate was used to calculate the Darcy 
permeability after puncture. 
2.6 Statistical analysis 
One-way analysis of variance (ANOVA) was used to perform the statistical analysis 
where appropriate, considering significance at  < 0.05. 
3. Results 
3.1 Physicochemical properties 
Figure 1A shows the full infrared absorbance spectra of samples PP, PFS, FF, FFS, BFS, 
ENC, EtOH, and MeOH. By comparing sample PP with PFS, and FF with FFS, it is possible 
to conclude that both polyurethane and fibroin retain their overall characteristic features after 
dissolution within the proposed solvent system. In fact, the spectrum of PP is comparable to 
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the PFS aside from a small decrease in absorbance on the two major peaks, at 1740-1735 cm
-
1
 (carbonyl, C=O, 1750-1700 cm
-1
) and 1245-1240 cm
-1
 (ester, –C–O–C–, 1260-1230 cm
-1
), 
that could indicate a mild increase in hardness
(40)
. As to fibroin, typical absorbance bands of 
amides I (C=O stretching vibration), II (C-N stretching and N-H distortion vibration) and III 
(C-N stretching and N-H deformation vibration)
(27)
 were observed at peaks 1640, 1514 and 
1234 cm
-1
, respectively, on both FF and FFS, with the latter also retaining all the other nine 
original peaks (Fig. 1B). However, FFS showed a shift in the amides I, II, and III when 
compared to sample FF, with the first two shifting towards high wavelengths, and the latter 
significantly increasing the 1260 cm
-1
 shoulder. This indicates that the used solvent mixture 
induces a crystallization effect on fibroin, with the development of β-sheet molecular 
conformations; the effect is observed, as well, when fibroin is blended with polyurethane in 
sample BFS. Besides that, the analysis of sample BFS confirms that also after blending 
fibroin and polyurethane maintain their characteristic features, since all peaks detected 
independently on FFS and PFS were observed in the BFS spectrum, as main peaks or sub-
peaks. Interestingly, ENC samples, i.e. electrospun non-crystallized meshes manufactured 
from the same solution as BFS (cast) samples, did not show a peak shifting in amides I, II, 
and III as observed in samples FFS and BFS, hinting at the absence of solvent-related 
crystallization effect upon electrospinning. A possible reason might be the difference in 
exposure time of fibroin to the solvent mixture, since solvent casting occurred overnight, 
during several hours, while each electrospinning session (i.e. contact of fibroin with solvents 
within the solution) took only a couple of hours. Apart from this, the spectrum of ENC was 
an overlap of FF together with PP or PFS, allowing to conclude that the proposed 
electrospinning protocol does not induce significant changes in the raw materials. As regards 
post-processing treatments, EtOH and MeOH spectra were identical, both showing a 
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crystallization effect in the amide I region in comparison with non-treated electrospun 
samples (ENC). 
Since PP and PFS showed no absorbance on the amide I region, a detailed analysis of the 
β-sheet contribution was conducted in this region (Fig. 1C, areas highlighted in grey). As 
shown in the Supplementary Information, deconvolution of the absorbance peak of amide I, 
in all samples, enabled the quantification of the total β-sheet contribution (crystallization 
index, Ci, Table 2), that resulted 31.4% ± 3.3%, 39.4% ± 2.1%, 37.9% ± 0.5%, 28.4% ± 
0.8%, 40.5% ± 0.9%, and 39.6% ± 1.1% for FF, FFS, BFS, ENC, EtOH and MeOH, 
respectively, confirming the above reported conclusions regarding the crystallization effect of 
solvents, electrospinning, ethanol and methanol treatments. Further deconvolution analysis 
revealed that the crystallization effect caused by the solvent mixture (FFS, BFS) was related 
to the formation of weak β-sheets or aggregated β-strands observed on sub-peaks 1703-1697 
cm
-1
 and 1621-1616 cm
-1
. In fact, inter- and intramolecular strong β-sheets typically observed 




 were not significant on FFS or BFS versus 
FF or ENC samples, but were indeed pronounced on samples EtOH and MeOH, revealing a 
high content of strong β-sheets induced by both crystallization treatments. 
Figure 2 represents the heat flow during the heating ramp of DSC performed on samples 
PP, PFS, FF, FFS, BFS, ENC, EtOH, and MeOH, allowing the extrapolation of the 
characteristic transitions of each sample (glass transition temperature, Tg, crystallization 
temperature, Tc, and degradation temperature Td, summarized in Table 2). Highlighted in 
grey are the degradation transitions ascribed to fibroin (around 270-300°C) and polyurethane 
(approximately between 320 and 400°C), which again confirmed the persistence of both 
materials in blended samples. More in details, the conclusions drawn above as regards the 
crystallization effect of solvents, electrospinning and post-treatments are corroborated by the 
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comparison of the crystallization temperatures of FFS (230°C), BFS (226°C), ENC (217°C), 
EtOH (223°C), and MeOH (227°C) as compared to FF (217°C) samples.  
3.2 Structure and morphology 
Electrospun hybrid tubular meshes appeared as white hollow cylinders, with an overall 
length of about 22 cm (Fig. 3A) and inner diameter of approximately 7 mm. SEM images 
revealed the presence of a fibrous morphology in all samples SF25PU75 (Fig. 3B), 
SF50PU50 (Fig. 3C) and SF75PU25 (Fig. 3D). There was a reduced presence of beads in 
SF50PU50 confirming suitable electrospinning parameters for this blend ratio. Diameter 
analysis revealed a distribution within an overall range of 0.050-2.150 µm. A higher fibre 
diameter polydispersity was detected on SF25PU75 (Fig. 3E) and SF75PU25 (Fig. 3G) as 
compared to SF50PU50 (Fig. 3F), which showed a more condensed range of fibre diameter 
between 0.050-0.800 µm, with an average of 0.316 ± 0.121 µm, confirming optimal 
fabrication parameters for this formulation. The main morphological characteristics of the 
electrospun hybrid meshes are summarized in Table 3. 
3.3 Mechanical properties 
Figure 4 shows the stress-strain plots of the axial tensile tests of SF25PU75 (Fig. 4A), 
SF50PU50 (Fig. 4B), and SF75PU25 (Fig. 4C) dog-bone specimens. Below, histograms 
show average values and standard deviations (N=3) of the Young’s modulus (Fig. 4D), stress 
at break (Fig. 4E) and elongation at break (Fig. 4F) of the three blend formulations. A 
statistically significant increase in Young’s modulus is observed in formulations with 
increasing fibroin content, from 3.96	±	0.37 MPa for SF25PU75, to 10.60	±	1.52 MPa for 
SF50PU50 and 23.50±1.89 MPa for SF75PU25, while an increasing elongation at break is 
seen in samples with increasing polyurethane content (173 ± 24% for SF25PU75, 127	±	31% 
for SF50PU50 and 93	±	17% for SF75PU25). Interestingly, stress at break revealed no 
significant difference between different blend ratios, with a mean value of 3.70	±	0.30 MPa. 
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Table 3 also summarizes the main mechanical properties of the electrospun hybrid meshes. 
ePTFE samples showed an average Young’s modulus of 34.66 MPa, elongation at break 
of 87.77%, and stress at break of 18.73 MPa. 
3.4 Permeability 




















, respectively (Table 3). These were in the same order of magnitude of commercially 





. The higher standard deviation in permeability of samples SF25PU75 and SF75PU25 was 
in line with the frequency in the presence of beads within the same samples, that would 
require optimization of processing parameters for the corresponding formulations. Samples 
ePTFE and 3-layer ePTFE were impermeable at 120 mmHg. 
3.5 Permeability after puncture 
After puncturing the electrospun meshes with a standard haemodialysis needle (15G), the 
permeability increased by four orders of magnitude in samples SF25PU75, SF50PU50, and 







 (Table 3), respectively, following the same trend of the 




. The gold standard 
arteriovenous vascular graft composed of an elastomer and ePTFE (3-layer ePTFE), deemed 





contrast, the traditional ePTFE graft was completely outperformed, showing a permeability 
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Despite the increasing interest lately raised by the so-called “in situ approach” to tissue 
engineering
(1)–(5)
, the industrial practicability and the clinical applicability of this strategy, 
traditionally relying on the use of fully degradable scaffolds, is far from being a reality. The 
scarcely controllable degradation rate of these scaffolds, which would likely be highly site- 
and patient-dependent, will make their regulatory approval and clinical transferability, at the 
very least, complex and adventurous. This is especially true for those applications (e.g. in the 
cardiovascular district) where a mismatch between the degradation rate of the scaffold and 
the production of new tissue by the host could dramatically result in the implant’s failure, and 
ultimately in the patient loss. To overcome this limitation, a “hybrid” approach to in situ 
tissue engineering could be adopted, based on the use of semi-degradable scaffolds 
combining a natural, biodegradable material – typically showing superior bioactivity and 
biocompatibility - with a synthetic, non-degradable one, granting a permanent backbone with 
adjustable and stable mechanical properties. This type of scaffold could be particularly 
beneficial in the field of vascular accesses (i.e. the arteriovenous shunts that allow for 
haemodialysis), where there is an urgent, unmet, global need for grafts that show suitable 
mechanical properties for early cannulation (i.e. that can be punctured immediately after 
implantation), as well as the capability to integrate and remodel in the long-term, which is 
known to be the key to a positive clinical outcome
(6)
. 
Based on this rationale, in this work we report the successful blending of regenerated silk 
fibroin with an aromatic, medical grade, highly biocompatible poly-carbonate-urethane
(38)
 
by using a solvent mixture of formic acid and dichloromethane, and the manufacture of 
electrospun hybrid tubular meshes, whose properties can be tuned according to the respective 
ratios of the raw materials in the blend. Indeed, our approach overcomes the limitations of 
several studies, already cited in the introductory section in this work, coupling fibroin and 
polyurethane in an attempt at combining the properties of natural and synthetic materials. In 
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particular, making use of solvents addressed by the European Pharmacopeia
(35)
, and blending 
fibroin together with a non-degradable polyurethane, we offer a potential industrially-
sustainable solution to regulatory hurdles (related to residual solvents and degradable 
polyurethanes) and technical issues (the separation of fibroin and polyurethane during 
processing). 
In our study, fibroin and polyurethane were processed through several steps, namely: 
dissolution, blending, electrospinning and post-treatment, which could have altered the 
materials’ intrinsic properties. The first part of the work, therefore, was dedicated to the 
investigation of the effects of each processing step on the raw materials (used in a 1:1 ratio in 
the blend formulations, Table 1). 
Physicochemical analyses (Fig. 1, Fig. 2, Table 2) demonstrated that both materials 
retained their characteristic features after dissolution within the proposed solvent system, and 
allowed to rule out possible denaturation, degradation, or chemical reactions between them in 
the blend; also, electrospun blend samples did not show significant effects on the raw 
materials if compared with cast blend films. Peculiar attention was dedicated to the analysis 
of the effect of the different processing steps on the crystallization of fibroin. The degree of 
crystallinity of silk fibroin, which is related to its molecular conformations (fraction of 
β-sheets in relation to α-helix and random turns
(39)
), is in fact known to significantly 
affect the material’s characteristics, e.g. in terms of solubility, mechanical properties, 
and degradation rate
(41)
. Indeed, regenerated fibroin can be water soluble and 
mechanically unstable in the amorphous state (higher α-helix fraction) or insoluble and 
mechanically stable in the crystalline state (predominant β-sheet fraction)
(42),(43)
. In the 
perspective, pursued in this work, of an industrially sustainable scaffold manufacturing 
process, the characterization, and possibly the control of the degree of crystallization of 
fibroin, is imperative to ensure reproducibility of the process and repeatability of the 
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product’s features (e.g., shelf life, in vivo degradation rate, stiffness). To this purpose, 
deconvolution of the amide I peak allowed to calculate the crystallization index (Ci) of 
fibroin-containing samples. As regards the post-processing treatments, we demonstrated that 
the proposed ethanol-based protocol induces a similar crystallization effect as compared to 
the traditional methanol-based one (more expensive and hazardous). Interestingly, both EtOH 
and MeOH samples revealed a higher glass transition temperature of 202ºC as compared to 
the 181.3-182.6ºC recorded in all other samples. Hu et al. also analysed fibroin samples 
crystallized with methanol, by DSC, and likewise observed a glass transition temperature of 
202 ºC, indicating that this effect is caused by β-sheet crystallization
(39)
. However, the same 
was not observed in samples FFS an BFS, where the glass transition temperature remained 
equal to FF samples, but both the crystallization temperature and index were in line with 
EtOH and MeOH samples. Deconvolution of the FTIR absorbance of amide I peak, in all 
samples, revealed that the crystallization effect caused by the overnight exposure to the 
solvent mixture (FFS, BFS) was related to the formation of weak β-sheets or aggregated β-
strands observed on sub-peaks 1703-1697 cm
-1
 and 1621-1616 cm
-1
. In fact, inter- and 





 were not significant on FFS or BFS versus FF samples, but were indeed 
pronounced on samples EtOH and MeOH, revealing a high content of strong β-sheets 
induced by both crystallization treatments. Upon observing that the effects of ethanol and 
methanol produced the same type and degree of crystallization, the average spectrum of 
EtOH samples was subtracted from the MeOH average, to evaluate what remained (see 
Supplementary Information): interestingly, three major peaks were observed at 1740-1720 
cm
-1
 and 1260-1230 cm
-1
, which coincide with characteristic peaks of formic acid and 
dichloromethane
(44)
. Although the typical peaks of polyurethane and fibroin fall in these 
regions, not allowing a trustworthy quantitative analysis by deconvolution, this result – not 
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surprisingly - indicates that the additional washing steps and time associated to the ethanol 
post-processing treatment were also more effective in removing residual solvents than the 
simple soaking in methanol. As regards the solvents used in this study, it is worth noticing 
that, while formic acid is included in Class 3 (Solvents with low toxic potential) by the 
European Pharmacopoeia
(35)
, dichloromethane belongs to Class 2 (Solvents to be 
limited), with a maximum concentration allowed of 600 ppm. Indeed, more refined 
analyses (e.g. thermogravimetric analysis, TGA) will need to be performed on the final 
product (i.e., after sterilization) to ensure a quantification of solvent residuals within the 
mesh; however, it has to be considered that additional post-processing steps, potentially 
effective in removing residual solvents, can still be explored, e.g. vacuum drying. 
After assessing the dissolution, blending, electrospinning and post-treatment techniques, 
our study focused on the evaluation of the applicability of the proposed process to blends 
with different respective ratios of fibroin and polyurethane. To this purpose, hybrid tubular 
meshes were electrospun using solutions with 1:3 (SF25PU75), 1:1 (SF50PU50), 3:1 
(SF25PU75) ratios of fibroin and polyurethane. The meshes were characterized in terms of 
morphology, and, envisioning their possible use as substrates for vascular grafts, the 
mechanical properties and permeability were also evaluated. 
SEM micrographs revealed a fibrous morphology mostly at the sub-micrometric level, 
with virtually indistinguishable, intermingled fibroin/polyurethane fibres (Fig. 3). The fact 
that fibroin and polyurethane respond to electrospinning and post-processing treatments 
without undergoing separation and/or delamination, as elsewhere reported for 
composite/coated scaffolds
(30)
, reassures about the robustness of the proposed technique and 
suggests that the material could show potential for a gradual in situ remodelling of the fibroin 
portion of the scaffold, with the polyurethane backbone being incorporated into the newly-
formed tissue, sustaining the mechanical properties of the overall implant. 
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Such a stable coalescence between fibroin and polyurethane in all the formulations was 
confirmed by the uniaxial tensile behaviour of the electrospun samples (Fig. 4), which 
showed a neat and sharp profile, with no signs of the saw-toothed morphology typical of 
delaminating structures. Not surprisingly, mechanical tests also confirmed that increasing the 
fibroin content in the blend significantly increases the stiffness of the mesh, whereas 
increasing the polyurethane content in the blend determines an increase in the elongation at 
break (Table 3); this fact shows the possibility of  tuning of the mechanical properties of the 
scaffold to the ones in the implant site, which is known to be a crucial factor especially in the 
vascular field, where graft-vessel compliance mismatch is recognized as one of the major 
determinants of grafts’ failures
(45)
. Indeed, samples SF25PU75 and SF50PU50 
demonstrated a Young’s modulus in line with the values reported in the literature for 
peripheral arteries, i.e. 1-10 MPa, such as the radial and brachial arteries
(46)–(48)
. In contrast, 
our tests revealed that ePTFE has a Young’s modulus around 35 MPa; although the 
literature is inconsistent in reporting the mechanical properties of ePTFE (Young’s 
modulus of tens of MPa
(49)
 to few GPa
(50)
), possibly due to different types of grafts under 
study, a clear divergence in mechanical properties is observed when compared with 
peripheral arteries. Also, no significant difference between the formulations was observed 
in terms of stress at break, possibly confirming that fibroin and polyurethane are perfectly 
coalescent within the mesh, and both contribute as load-bearing structures. 
Permeability tests (Fig. 5) allowed to verify that the electrospun meshes are characterized 





commercially available electrospun polyurethane grafts already used in the clinics (ES PU), 
hinting at their possibly favourable in situ behaviour in terms of avoidance of seroma 
formation. The measurements also confirmed that ePTFE-containing grafts, known to suffer 
from scarce integration with the host tissue, are in fact impermeable at 120 mmHg. Finally, 
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the evaluation of permeability after puncture with a dialysis needle (15G) showed that the 




) to the one of 
commercial grafts that are deemed to be suitable for early cannulation (ES PU and 3-layer 
ePTFE), i.e. capable of self-sealing after puncture and avoiding massive bleeding at the 
puncture site. 
In summary, herein we proposed a novel blending technique for fibroin and polyurethane, 
using industrially-sustainable solvents (affordable, moderately volatile, addressed by the 
European Pharmacopoeia), regenerated fibroin and a medical-grade poly-carbonate-urethane 
suitable for long-term implantation, which proved to be effective in maintaining the 
characteristic physicochemical features of the two materials. We also demonstrated the 
feasibility of electrospinning blend solutions with varying ratios of fibroin and polyurethane, 
to obtain hybrid tubular meshes possessing extracellular matrix-like nano-fibrous 
morphology, tuneable mechanical properties, and favourable permeability before and after 
puncture, therefore representing possible substrates for semi-degradable haemodialysis 
vascular accesses. 
Future work will focus on further optimization of the architectural structure of a novel 
arteriovenous graft for haemodialysis, whose performances will be characterized in vitro and 
in vivo, in view of an alternative, “hybrid” approach to in situ vascular tissue engineering. 
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Figure 1. FTIR spectra of samples PP, PFS, FF, FFS, BFS, ENC, EtOH, and MeOH, (A) at 
full scale, (B) between 1800-1100 cm
-1
 and (C) at the amide I region. Dashed lines represent 
the characteristic wavelengths of polyurethane (at 1740-1735 cm
-1
 and 1245-1240 cm
-1
) and 
fibroin (amides I, II and III around 1640, 1514 and 1234 cm
-1
). Regions highlighted in grey 
allow to detect the crystallization effect of solvents (FFS and BFS vs FF), electrospinning 
(ENC vs BFS), ethanol- and methanol-treatments (EtOH and MeOH vs ENC) on fibroin β-
sheet arrangements. 
Figure 2. DSC analysis plots of samples PP, PFS, FF, FFS, BFS, ENC, EtOH, and MeOH, 
showing the final heating phase. Highlighted in grey are the degradation transitions ascribed 
to fibroin (around 270-300°C) and polyurethane (approximately between 320 and 400°C). 
Figure 3. Structure and morphology of tubular electrospun hybrid meshes composed by a 
blend of fibroin and polyurethane. (A) Macroscopic appearance of an exemplifying 
SF50PU50 sample. SEM micrographs of samples SF25PU75 (B), SF50PU50 (C), and 
SF75PU25 (D), with a 10 µm scale bar. Histograms presenting the fibre diameter analysis of 
samples SF25PU75 (E), SF50PU50 (F), and SF75PU25 (G). 
Figure 4. Stress-strain plots of uniaxial tensile tests performed on samples SF25PU75 (A), 
SF50PU50 (B), and SF75PU25 (C), allowing for the calculation of Young’s modulus (D), 
stress at break (E) and elongation at break (F). Results are expressed as average ± standard 
deviation, =3. *: significance was considered at <0.05. 
Figure 5. Darcy permeability (k) of samples SF25PU75, SF50PU50, and SF75PU25, as 
compared to commercially available grafts (ES PU=polyurethane electrospun graft, 
ePTFE=expanded polytetrafluoroethylene graft, 3-layer ePTFE=three-layered graft 
containing ePTFE), before (white columns) and after (criss-cross columns) puncturing with a 
needle (15G) typically used in haemodialysis procedure (N≥3 for SF25PU75, SF50PU50, 
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SF75PU25, N=1 for commercial grafts). ES PU and 3-layer ePTFE are deemed to be grafts 
capable of self-sealing after retrieval of the needle (i.e. low permeability after puncture). 
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Table 1. Processing parameters used to prepare samples PP, PFS, FF, FFS, BFS, ENC, EtOH and MeOH, regarding concentration of raw 
materials and organic solvents used on solution preparation, electrospinning parameters and post-treatment times employed. SF=silk fibroin, 
PU=polyurethane, FA=formic acid, DCM=dichloromethane, t=processing time, ∆V=electrospinning voltage, d=distance between spinneret and 
collector, Q=flow rate of electrospinning solution, EtOH*=ethanol-based post-treatment, MeOH*=methanol-based post-treatment. 
Sample 
acronym 



















PP Polyurethane pellets - 100% - - - - - - - 
PFS Solvent cast polyurethane films - 2% 3:2 O/N - - - - - 
FF Aqueous fibroin films 100% - - - - - - - - 
FFS Solvent cast fibroin films 2% - 3:2 O/N - - - - - 
BFS Solvent cast blend films 2% 2% 3:2 O/N - - - - - 
ENC 
Electrospun hybrid mesh non-
crystallized 
2% 2% 3:2 8h 17 19 2.5 - - 
EtOH 
Electrospun hybrid mesh crystallized 
with ethanol 
2% 2% 3:2 8h 17 19 2.5 20:00 - 
MeOH 
Electrospun hybrid mesh crystallized 
with methanol 
2% 2% 3:2 8h 17 19 2.5 - 00:10 
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Figure 1. FTIR spectra of samples PP, PFS, FF, FFS, BFS, ENC, EtOH, and MeOH, (A) at full scale, (B) 
between 1800-1100 cm-1 and (C) at the amide I region. Dashed lines represent the characteristic 
wavelengths of polyurethane (at 1735-1740 cm-1 and 1240-1245 cm-1) and fibroin (amides I, II and III 
around 1640, 1514 and 1234 cm-1). Regions highlighted in grey allow to detect the crystallization effect of 
solvents (FFS and BFS vs FF), electrospinning (ENC vs BFS), ethanol- and methanol-treatments (EtOH and 
MeOH vs ENC) on fibroin β-sheet arrangements.  
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Table 2. Physicochemical analysis of samples PP, PFS, FF, FFS, BFS, ENC, EtOH and 
MeOH: crystallization index (Ci), glass (Tg), crystallization (Tc) and degradation (Td) 
temperatures. Degradation temperatures ascribed to fibroin (1°) and polyurethane (2°) are 











FF 31.4% ± 3.3% 181.3 217 292 
FFS 39.4% ± 2.1% 182.6 230 287 
PP - - - 369 
PFS - - - 354 
BFS 37.9% ± 0.5% 182.6 226 
1° - 293 
2° - 358 
ENC 28.4% ± 0.8% 182.6 217 
1° - 295 
2° - 357 
EtOH 40.5% ± 0.9% 202 223 
1° - 294 
2° - 324 
MeOH 39.6% ± 1.1% 202 227 
1° - 295 
2° - 339 
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Figure 2. DSC analysis plots of samples PP, PFS, FF, FFS, BFS, ENC, EtOH, and MeOH, showing the final 
heating phase. Highlighted in grey are the degradation transitions ascribed to fibroin (around 270-300°C) 
and polyurethane (approximately between 320 and 400°C).  
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Figure 3. Structure and morphology of tubular electrospun hybrid meshes composed by a blend of fibroin 
and polyurethane. (A) Macroscopic appearance of an exemplifying SF50PU50 sample. SEM micrographs of 
samples SF25PU75 (B), SF50PU50 (C), and SF75PU25 (D), with a 10 µm scale bar. Histograms presenting 
the fibre diameter analysis of samples SF25PU75 (E), SF50PU50 (F), and SF75PU25 (G).  
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Table 3. Quantitative characteristics of all formulations of electrospun hybrid meshes: SF25PU75, SF50PU50 and SF75PU25, regarding wall 
thickness, fibre diameter, mechanical properties, and permeability (k) before and after puncture. 
 
 
SF25PU75 SF50PU50 SF75PU25 
Wall thickness (mm) 130±	26 164±22 182±21 
ᴓ
fibre
 (mm) 0.348±0.329 0.316±0.121 0.559±0.203 
E (MPa) 3.96±0.37 10.60±1.52 23.50±1.89 
Elongation at break 
(%) 
173±24 127±31 93±17 
Stress at break (MPa) 3.65±0.13 3.35±0.58 4.09±0.44 
k (m
2
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Figure 4. Stress-strain plots of uniaxial tensile tests performed on samples SF25PU75 (A), SF50PU50 (B), 
and SF75PU25 (C), allowing for the calculation of Young’s modulus (D), stress at break (E) and elongation at 
break (F). Results are expressed as average ± standard deviation, =3. *: significance was considered at 
<0.05.  
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Figure 5. Darcy permeability (k) of samples SF25PU75, SF50PU50, and SF75PU25, as compared to 
commercially available grafts (ES PU=polyurethane electrospun graft, ePTFE=expanded 
polytetrafluoroethylene graft, 3-layer ePTFE=three-layered graft containing ePTFE), before (white columns) 
and after (criss-cross columns) puncturing with a needle (15G) typically used in haemodialysis procedure 
(N≥3 for SF25PU75, SF50PU50, SF75PU25, N=1 for commercial grafts). ES PU and 3-layer ePTFE are 
deemed to be grafts capable of self-sealing after retrieval of the needle (i.e. low permeability after 
puncture).  
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